Conavi Medical Raises C$10 Million in Public Offering | Lucid Diligence Brief
Conavi Medical’s C$10M Financing Puts Novasight U.S. Adoption and Funding…
Cardiovascular Strategic Roundup | June 25–July 21, 2026
Cardiovascular Strategic Roundup exploring Developments and Competitive Shifts…
Lucid Diligence Brief: Axoft $55 million Series A
Lucid Diligence Brief: Axoft $55 million Series A Professional audiences only.…
Lucid Diligence Brief: China approves Boruik Kang (Neuracle) invasive BCI implant for paralysis
Lucid Diligence Brief: China approves Boruik Kang (Neuracle) invasive BCI…
Lucid Diligence Brief: Cognito Therapeutics $105 million Series C
Lucid Diligence Brief: Cognito Therapeutics $105 million Series C Professional…
Lucid Diligence Brief: CorriXR × InhaTarget × Merxin, inhaled CRISPR therapy for lung cancer
Lucid Diligence Brief: CorriXR × InhaTarget × Merxin, inhaled CRISPR therapy…
Lucid Diligence Brief: Clairity's $43 million Series B for Clairity Breast
Lucid Diligence Brief: Clairity's $43 million Series B for Clairity Breast…
Lucid Diligence Brief: ENA Respiratory Series B for Intranasal INNA-051
Lucid Diligence Brief: ENA Respiratory Series B for intranasal INNA-051…
Artificial Intelligence and Digital Health Weekly News - September 1st 2025
AI in Healthcare Update: Obesity, Heart & AI and more…
Respiratory Weekly News - August 14th 2025
This Week in Respiratory Health: Global Respiratory Initiatives, CRISPR AMR…
Respiratory Weekly News - August 8th 2025
Respiratory & Pulmonary Health Updates: mRNA Asthma Therapies, AI-Powered…